Clinical significance of a single staphylococcus lugdunensis-positive blood culture

Journal of Clinical Microbiology

Volumn 49, Issue 4, 2011, Pages 1697-1699

  Fadel, Hind J ^a   Patel, Robin ^a   Vetter, Emily A ^a   Baddour, Larry M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFALEXIN; CEFAZOLIN; CEFEPIME; CEFTRIAXONE; CLINDAMYCIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; VANCOMYCIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ASPIRATION PNEUMONIA; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIUM CONTAMINATION; BACTERIUM DETECTION; BLOOD CULTURE; COMORBIDITY; HUMAN; LEUKOCYTOSIS; MEDICAL RECORD REVIEW; NEUTROPENIA; PRIORITY JOURNAL; RISK FACTOR; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS LUGDUNENSIS; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BLOOD; FEMALE; HUMANS; MALE; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS LUGDUNENSIS;

STAPHYLOCOCCUS LUGDUNENSIS;

EID: 79953873735     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02058-10     Document Type: Article

References (13)

1. Choi, S. H., et al. 2010. Incidence, characteristics, and outcomes of Staphylococcus lugdunensis bacteremia. J. Clin. Microbiol. 48:3346-3349.
2. Ebright, J. R., N. Penugonda, and W. Brown. 2004. Clinical experience with Staphylococcus lugdunensis bacteremia: A retrospective analysis. Diagn. Microbiol. Infect. Dis. 48:17-21. (Pubitemid 38167495)
3. Favre, B., et al. 2005. Nosocomial bacteremia: Clinical significance of a single blood culture positive for coagulase-negative staphylococci. Infect. Control Hosp. Epidemiol. 26:697-702. (Pubitemid 41169739)
4. Fleurette, J., et al. 1989. Clinical isolates of Staphylococcus lugdunensis and S. schleiferi: Bacteriological characteristics and susceptibility to antimicrobial agents. Res. Microbiol. 140:107-118. (Pubitemid 19129860)
5. Freney, J., et al. 1988. Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov., two species from human clinical specimens. Int. J. Syst. Bacteriol. 38:168-172.
6. Guttmann, G., S. Garazi, and D. Van Linthoudt. 2000. Spondylodiscitis due to Staphylococcus lugdunensis. Clin. Exp. Rheumatol. 18:271-272.
7. Hellbacher, C., E. Tornqvist, and B. Soderquist. 2006. Staphylococcus lugdunensis: Clinical spectrum, antibiotic susceptibility, and phenotypic and genotypic patterns of 39 isolates. Clin. Microbiol. Infect. 12:43-49. (Pubitemid 43372238)
8. Herchline, T. E., and L. W. Ayers. 1991. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J. Clin. Microbiol. 29:419-421.
9. Kleiner, E., A. B. Monk, G. L. Archer, and B. A. Forbes. 2010. Clinical significance of Staphylococcus lugdunensis isolated from routine cultures. Clin. Infect. Dis. 51:801-803.
10. Patel, R., et al. 2000. Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: A 20-year experience. J. Clin. Microbiol. 38:4262-4263. (Pubitemid 32233241)
11. Seifert, H., D. Oltmanns, K. Becker, H. Wisplinghoff, and C. von Eiff. 2005. Staphylococcus lugdunensis pacemaker-related infection. Emerg. Infect. Dis. 11:1283-1286. (Pubitemid 41045339)
12. Souvenir, D., et al. 1998. Blood cultures positive for coagulase-negative staphylococci: Antisepsis, pseudobacteremia, and therapy of patients. J. Clin. Microbiol. 36:1923-1926. (Pubitemid 28277777)
13. Zinkernagel, A. S., et al. 2008. Significance of Staphylococcus lugdunensis bacteremia: Report of 28 cases and review of the literature. Infection 36:314-321.